Cargando…

Identification, genetic testing, and management of hereditary melanoma

Several distinct melanoma syndromes have been defined, and genetic tests are available for the associated causative genes. Guidelines for melanoma genetic testing have been published as an informal “rule of twos and threes,” but these guidelines apply to CDKN2A testing and are not intended for the m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leachman, Sancy A., Lucero, Olivia M., Sampson, Jone E., Cassidy, Pamela, Bruno, William, Queirolo, Paola, Ghiorzo, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385190/ https://www.ncbi.nlm.nih.gov/pubmed/28283772 http://dx.doi.org/10.1007/s10555-017-9661-5

Ejemplares similares

Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma
por: Spagnolo, Francesco, et al.
Publicado: (2014)

Lack of GNAQ and GNA11 Germ-Line Mutations in Familial Melanoma Pedigrees with Uveal Melanoma or Blue Nevi
por: Hawkes, Jason E., et al.
Publicado: (2013)

TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclear
por: Monti, Paola, et al.
Publicado: (2017)

Altered transcriptome signature of phenotypically normal skin fibroblasts heterozygous for CDKN2A in familial melanoma: relevance to early intervention
por: Fan, Meiyun, et al.
Publicado: (2013)

Unaffected family members report improvements in daily routine sun-protection 2 years following melanoma genetic testing
por: Aspinwall, Lisa G., et al.
Publicado: (2014)

Beyond red hair and sunburns: Uncovering the molecular mechanisms of MC1R signaling and repair of UV-induced DNA damage
por: Cassidy, Pamela B., et al.
Publicado: (2015)

BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies
por: Spagnolo, Francesco, et al.
Publicado: (2015)

Selenium for the Prevention of Cutaneous Melanoma
por: Cassidy, Pamela B., et al.
Publicado: (2013)

Detection of Exosomal miRNAs in the Plasma of Melanoma Patients
por: Pfeffer, Susan R., et al.
Publicado: (2015)

The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
por: Vanni, Irene, et al.
Publicado: (2020)

From Melanocyte to Malignant Metastatic Melanoma
por: Manga, Prashiela, et al.
Publicado: (2010)

A Glance at Molecular Advances in Cancer Genetics: A Baffling Puzzle Still to Be Solved
por: Ghiorzo, Paola, et al.
Publicado: (2023)

Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations
por: Bruno, William, et al.
Publicado: (2017)

Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations
por: Bruno, William, et al.
Publicado: (2018)

CDKN2A testing and genetic counseling promote reductions in objectively measured sun exposure one year later
por: Stump, Tammy K., et al.
Publicado: (2019)

Pancreatic Cancer: From Genetic Mechanisms to Translational Challenges
por: Pastorino, Lorenza, et al.
Publicado: (2023)

Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry
por: Bruno, William, et al.
Publicado: (2016)

Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup
por: Bruno, W., et al.
Publicado: (2022)

Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants
por: Spagnolo, Francesco, et al.
Publicado: (2021)

Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients
por: Ciccarese, Giulia, et al.
Publicado: (2020)

Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting
por: Vanni, Irene, et al.
Publicado: (2023)

The benefit of early‐stage diagnosis: A registry‐based survey evaluating the quality of life in patients with melanoma
por: Young, Jade N., et al.
Publicado: (2023)

Combined Use of Dermoscopy, Reflectance Confocal Microscopy and Ex-Vivo Gene Expression Profiling to Detect a Micro-Melanoma Less Than 1 mm in Diameter
por: Witkowski, Alexander, et al.
Publicado: (2023)

Current State of Target Treatment in BRAF Mutated Melanoma
por: Tanda, Enrica Teresa, et al.
Publicado: (2020)

Performance of a 31‐gene expression profile test in cutaneous melanomas of the head and neck
por: Gastman, Brian R., et al.
Publicado: (2019)

A Systematic Review of Evidence-Based High School Melanoma Prevention Curricula
por: Calco, Gina N., et al.
Publicado: (2023)

Reply to Reimann et al.
por: Clarke, Loren E., et al.
Publicado: (2019)

Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1
por: Pastorino, Lorenza, et al.
Publicado: (2020)

The p16(INK4A) tumor suppressor regulates cellular oxidative stress
por: Jenkins, Noah C., et al.
Publicado: (2010)

Reply to: Comments on “Proposed approach for reusing surgical masks in COVID-19 pandemic”
por: Liu, Yuangang, et al.
Publicado: (2020)

Proposed approach for reusing surgical masks in COVID-19 pandemic
por: Liu, Yuangang, et al.
Publicado: (2020)

Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
por: Helgadottir, Hildur, et al.
Publicado: (2020)

Editorial: The Evolving Role of Immunotherapy in Non-Melanoma Skin Cancers
por: Guida, Michele, et al.
Publicado: (2022)

Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
por: Vanni, Irene, et al.
Publicado: (2020)

Linkage analysis of extended high-risk pedigrees replicates a cutaneous malignant melanoma predisposition locus on chromosome 9q21
por: Cannon-Albright, Lisa A, et al.
Publicado: (2012)

The role of genetic testing in management of hereditary chronic pancreatitis
por: Walker, Nicholas Faure, et al.
Publicado: (2013)

Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway
por: Levin, Trine, et al.
Publicado: (2016)

Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice
por: Grossman, Douglas, et al.
Publicado: (2019)

The Mole Mapper Study, mobile phone skin imaging and melanoma risk data collected using ResearchKit
por: Webster, Dan E., et al.
Publicado: (2017)

Genes and Genetic Testing in Hereditary Ataxias
por: Sandford, Erin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nl8mj1s8kfs62f6mln9n88ogbv